Jane Street’s Adial Pharmaceuticals ADIL Stock Holding History

Jane Street’s Portfolio ADIL Stock Details ADIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.2K	Buy	+32,119	New	+$63.6K	﹤0.01%	10707
2026 Q1	–	Sell	-4,874	Closed	-$26.8K	–	11422
2025 Q4	$26.8K	Buy	4,874 +4,380	+887%	+$35.5K	﹤0.01%	10667
2025 Q3	$4.36K	Sell	494 -500	-50%	-$4.87K	﹤0.01%	10613
2025 Q2	$7.51K	Buy	+994	New	+$15K	﹤0.01%	9417
2022 Q3	–	Sell	-22	Closed	-$19K	–	9608
2022 Q2	$19K	Buy	+22	New	+$19.9K	﹤0.01%	9171
2019 Q2	–	Sell	-49	Closed	-$105K	–	5060
2019 Q1	$105K	Buy	+49	New	+$146K	﹤0.01%	4767

Other funds holding ADIL

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Manchester Capital Management Manchester, Vermont $768M AUM 29.32% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's ADIL Position: Q2 2026 in Review

Jane Street opened a new position in Adial Pharmaceuticals (ADIL) in Q2 2026: 32,119 shares worth $82.2K. The stake represents ﹤0.01% of the portfolio and ranks #10707 among its holdings. This is a return to the name: Jane Street previously reported a position in ADIL as recently as Q4 2025.

Jane Street first reported a position in ADIL in Q1 2019 and has held it in 6 quarters since. The position peaked at $105K in Q1 2019. 17 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.

Jane Street held 32,119 shares of Adial Pharmaceuticals worth $82.2K as of Q2 2026.
Adial Pharmaceuticals was a new Jane Street position in Q2 2026.
Adial Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10707 holding.
Jane Street first reported a position in Adial Pharmaceuticals in Q1 2019 and has held it in 6 quarters since.
Jane Street's Adial Pharmaceuticals position peaked at $105K in Q1 2019.
17 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.